# S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat

> **NCT02608788** · PHASE4 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 380 (actual)

## Conditions studied

- Sore Throat

## Interventions

- **DRUG:** S.L.®
- **DRUG:** Difflam Forte ®
- **DRUG:** Acular®
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02608788
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2021-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608788, "S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02608788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*